XML 48 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Debt Securities
9 Months Ended
Sep. 30, 2019
Debt Securities  
Debt Securities

NOTE 2 — Debt Securities

Available-for-Sale Securities

The amortized cost, gross unrealized gains and losses and estimated fair value of securities available for sale were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

    

Cost

    

Gains

    

Losses

    

Value

 

 

(In thousands)

September 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities – agency

 

$

25,541

 

$

609

 

$

(93)

 

$

26,057

Collateralized mortgage obligations (CMO’s) – agency

 

 

113,085

 

 

449

 

 

(426)

 

 

113,108

Total available-for-sale

 

$

138,626

 

$

1,058

 

$

(519)

 

$

139,165

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities – agency

 

$

27,384

 

$

15

 

$

(724)

 

$

26,675

Collateralized mortgage obligations (CMO’s) – agency

 

 

121,913

 

 

32

 

 

(2,922)

 

 

119,023

Total available-for-sale

 

$

149,297

 

$

47

 

$

(3,646)

 

$

145,698

 

Mortgage-backed securities include all residential pass-through certificates guaranteed by FHLMC, FNMA, or GNMA and the CMO’s are backed by government agency pass-through certificates. The 2019 and 2018 pass-through certificates are fixed rate instruments. CMO’s, by virtue of the underlying residential collateral or structure, are fixed rate current pay sequentials or planned amortization classes (PAC’s). As actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations, these securities are not considered to have a single maturity date.

There were no sales or calls of securities for the three and nine months ended September 30, 2019 and 2018.

At September 30, 2019, securities having a fair value of $114.8 million were pledged to the Federal Home Loan Bank of New York (FHLB) for borrowing capacity totaling $109.7 million. At December 31, 2018, securities having a fair value of $120.7 million were pledged to the FHLB for borrowing capacity totaling $115.0 million. At September 30, 2019 and December 31, 2018, the Company had no outstanding FHLB advances.

At September 30, 2019, securities having a fair value of $24.3 million were pledged to the Federal Reserve Bank of New York (FRB) for borrowing capacity totaling $23.6 million. At December 31, 2018, securities having a fair value of $25.0 million were pledged to the FRB for borrowing capacity totaling $24.2 million. At September 30, 2019 and December 31, 2018, the Company had no outstanding FRB borrowings.

The following table provides the gross unrealized losses and fair value, aggregated by investment category and length of time the individual securities have been in a continuous unrealized loss position as of:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less Than 12 Months

 

12 Months or Longer

 

Total

 

    

Fair
Value

    

Gross
Unrealized
Losses

    

Fair
Value

    

Gross
Unrealized
Losses

    

Fair
Value

    

Gross
Unrealized
Losses

 

 

(In thousands)

September 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities – agency

 

$

 —

 

$

 —

 

$

9,926

 

$

(93)

 

$

9,926

 

$

(93)

CMO’s – agency

 

 

10,459

 

 

(85)

 

 

31,489

 

 

(341)

 

 

41,948

 

 

(426)

Total temporarily impaired securities

 

$

10,459

 

$

(85)

 

$

41,415

 

$

(434)

 

$

51,874

 

$

(519)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities - agency

 

$

9,528

 

$

(99)

 

$

15,497

 

$

(625)

 

$

25,025

 

$

(724)

CMO's - Agency

 

 

19,184

 

 

(73)

 

 

85,775

 

 

(2,849)

 

 

104,959

 

 

(2,922)

Total temporarily impaired securities

 

$

28,712

 

$

(172)

 

$

101,272

 

$

(3,474)

 

$

129,984

 

$

(3,646)

 

Management reviews the investment portfolio on a quarterly basis to determine the cause, magnitude and duration of declines in the fair value of each security. In estimating other-than-temporary impairment (OTTI), management considers many factors including: (1) the length of time and extent that fair value has been less than cost, (2) the financial condition and near term prospects of the issuer, (3) whether the market decline was affected by macroeconomic conditions, and (4) whether the Company has the intent to sell the security or more likely than not will be required to sell the security before its anticipated recovery. If either of the criteria regarding intent or requirement to sell is met, the entire difference between amortized cost and fair value is recognized as impairment through earnings. For debt securities that do not meet the aforementioned criteria, the amount of impairment is split into two components as follows: (1) OTTI related to credit loss, which must be recognized in the income statement and (2) OTTI related to other factors, which is recognized in other comprehensive income. The credit loss is defined as the difference between the present value of the cash flows expected to be collected and the amortized cost basis. The assessment of whether any other than temporary decline exists may involve a high degree of subjectivity and judgment and is based on the information available to management at a point in time. Management evaluates securities for OTTI at least on a quarterly basis, and more frequently when economic or market conditions warrant such an evaluation.

At September 30, 2019, securities in unrealized loss positions were issuances from government sponsored entities. Due to the decline in fair value being attributable to changes in interest rates, not credit quality and because the Company does not have the intent to sell the securities and it is likely that it will not be required to sell the securities before their anticipated recovery, the Company does not consider the securities to be other-than-temporarily impaired at September 30, 2019.

No impairment charges were recorded for the three and nine months ended September 30, 2019 and 2018.